Preparing your experience...
Back to Intelligence
Content Series • 0 pieces
Anatomy of Regulatory Capture
The McKinsey/FDA Case Study
A comprehensive examination of how structural conflicts of interest compromised pharmaceutical safety oversight during the opioid epidemic. This series documents the mechanisms, impacts, and lessons from one of the most significant regulatory failures in modern pharmaceutical history.
Intel Signals
Quick intelligence alerts highlighting key findings from the Congressional investigation.
Content coming soon
From the Field
Practical guidance for recognizing and preventing conflicts of interest in your organization.
Content coming soon
Deep Dives
Strategic analysis examining how structural conflicts become institutionalized.
Content coming soon
The Complete Case Study
Our comprehensive publication documenting the full scope of the McKinsey/FDA conflict.
Content coming soon
Primary Sources
House Oversight Committee Report
https://oversightdemocrats.house.gov/news/press-releases/committee-releases-report-uncovering-significant-conflicts-of-interest-at
DOJ Criminal Resolution
https://www.justice.gov/archives/opa/pr/justice-department-announces-resolution-criminal-and-civil-investigations-mckinsey-companys
UCSF/Johns Hopkins Document Archive
https://www.industrydocuments.ucsf.edu/opioids/collections/mckinsey-documents/
Massachusetts AG Settlement
https://www.mass.gov/news/ags-office-secures-573-million-settlement-with-mckinsey-for-turbocharging-opioid-sales-and-profiting-from-the-epidemic
Need conflict-free oversight?
NexVigilant provides independent vigilance intelligence without the structural conflicts that compromised FDA oversight.
Learn About Our ApproachSignal in the Static
The Weekly Update
Safety intelligence, regulatory updates, and signal detection alerts — delivered weekly.